rxstat › Shortages › Deferasirox

Deferasirox shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Deferasirox products are in shortage in Canada (1 of 21 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
1 / 21
In shortage since
Mar 10, 2026
Reports on file
47
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
PMS-DEFERASIROX (TYPE J)
360MG · TABLET · PHARMASCIENCE INC
DIN 02528312 · since Mar 10, 2026, no end estimate · Disruption of the manufacture of the drug.
Resolved
SANDOZ DEFERASIROX
250MG · TABLET FOR SUSPENSION · SANDOZ CANADA INCORPORATED
DIN 02464462 · ended Jun 15, 2026 · Disruption of the manufacture of the drug.
Resolved
TARO-DEFERASIROX (TYPE J)
90MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02507315 · ended Dec 12, 2025 · Other (Please describe in comments)
Resolved
TARO-DEFERASIROX (TYPE J)
360MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02507331 · ended Dec 10, 2025 · Other (Please describe in comments)
Resolved
TARO-DEFERASIROX (TYPE J)
180MG · TABLET · TARO PHARMACEUTICALS INC
DIN 02507323 · ended Dec 9, 2025 · Other (Please describe in comments)
Resolved
APO-DEFERASIROX
250MG · TABLET FOR SUSPENSION · APOTEX INC
DIN 02461552 · ended May 15, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ DEFERASIROX (TYPE J)
90MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489899 · ended Apr 21, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ DEFERASIROX (TYPE J)
360MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489910 · ended Apr 21, 2025 · Disruption of the manufacture of the drug.
Resolved
SANDOZ DEFERASIROX (TYPE J)
180MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489902 · ended Apr 21, 2025 · Demand increase for the drug.
Resolved
APO-DEFERASIROX (TYPE J)
180MG · TABLET · APOTEX INC
DIN 02485273 · ended Feb 20, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-DEFERASIROX
250MG · TABLET FOR SUSPENSION · APOTEX INC
DIN 02461552 · ended Dec 19, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-DEFERASIROX (TYPE J)
360MG · TABLET · APOTEX INC
DIN 02485281 · ended Aug 22, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 47 reports. All reports are on file with Health Canada.

What's happening

Deferasirox is currently affected by an active shortage report filed with Health Canada by PHARMASCIENCE INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Deferasirox is classified under “ALL OTHER THERAPEUTIC PRODUCTS” (ATC V03AC).

Recent changes

Common questions

When will Deferasirox be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Deferasirox in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (all other therapeutic products)

Widespread shortageMesna3 of 3 reported products affected · est. return Aug 31, 2026Widespread shortagePolystyrene Sulfonate3 of 6 reported products affected · est. return Oct 9, 2026Partial shortageDexrazoxane1 of 3 reported products affectedPartial shortageLeucovorin1 of 6 reported products affected · est. return Jul 24, 2026Partial shortageMethylene Blue1 of 2 reported products affectedPartial shortagePolystyrene Sulfonate1 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.